tiprankstipranks
Cidara Therapeutics (CDTX)
NASDAQ:CDTX

Cidara Therapeutics (CDTX) Financial Statements

650 Followers

Cidara Therapeutics Financial Overview

Cidara Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.382; its P/E ratio is -2.20; Cidara Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 12.72M---$ 40.74M
Gross Profit$ 12.72M----
EBIT$ -7.94M$ -12.21M$ 2.53M$ -10.19M$ 14.92M
EBITDA$ -7.66M$ -11.81M$ 2.85M$ -10.29M$ 15.23M
Net Income Common Stockholders$ -8.17M$ -12.36M$ 2.53M$ -10.30M$ 11.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 48.67M$ 50.43M$ 47.98M$ 32.73M$ 53.08M
Total Assets$ 63.47M$ 67.99M$ 81.47M$ 47.59M$ 66.86M
Total Debt$ 4.36M$ 4.54M$ 1.00M$ 1.32M$ 1.62M
Net Debt$ -44.31M$ -45.89M$ -46.98M$ -31.41M$ -51.46M
Total Liabilities$ 55.43M$ 52.57M$ 54.90M$ 50.50M$ 57.79M
Stockholders Equity$ 8.04M$ 15.41M$ 26.84M$ -2.90M$ 9.07M
Cash Flow-
Free Cash Flow$ -1.76M$ 2.71M$ -10.99M$ -21.01M$ 27.96M
Operating Cash Flow$ -1.63M$ 2.82M$ -10.90M$ -21.00M$ 27.97M
Investing Cash Flow$ -126.00K$ -107.00K$ -94.00K$ -9.00K$ -9.00K
Financing Cash Flow-$ -261.00K$ 26.24M$ 664.00K$ 107.00K
Currency in USD

Cidara Therapeutics Earnings and Revenue History

Cidara Therapeutics Debt to Assets

Cidara Therapeutics Cash Flow

Cidara Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis